5-Carboxy-2-fluorophenylboronic acid, 97.0%, 100g

(1R,2R)-2-(Pyridin-3-yl)cyclopropane-1-carboxylic acid, 5g

4-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile, 95.0%, 1g

2-(5-Formamido-1H-pyrazol-1-yl)ethyl formate, 95.0%, 100g

(S)-2-(2-CHLOROPHENYL)-2-((2-(THIOPHEN-2-YL)ETHYL)AMINO)ACETIC ACID, 95%, 100mg

anti-GST-tag mouse monoclonal, F50-3D12.2, 100 µg

5-Fluoro-3-methoxy-2-nitrobenzoic acid, 95.0%, 250mg

2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-2-methylpropanoic acid, 97%, 1g

[(R)-(+)-2,2�-bis(diphenylphosphino)-1,1�-binaphthyl][(1S,2S)-(-)-1,2-diphenylethylenediamine]RuCl2, 95%, 5g

(2S,5R)-Benzyl 5-((benzyloxy)amino)piperidine-2-carboxylate oxalate, 98%, 1g

2-Methoxy-5-(trifluoromethoxy)phenol, 95.0%, 10g

2,4-Dichloro-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine hydrochloride, 95.0%, 5g

2-HYDROXY-3-TERT-BUTYL BENZONITRILE, 97.0%, 1g